|
| PIK-293 Basic information |
Product Name: | PIK-293 | Synonyms: | PIK-293;2-[(4-Amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone;2-((4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one;PIK-293 USP/EP/BP;4(3H)-Quinazolinone, 2-[(4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl]-5-methyl-3-(2-methylphenyl)-;PIK-293;PIK293;PIK 293;2-[(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one;CS-539 | CAS: | 900185-01-5 | MF: | C22H19N7O | MW: | 397.43 | EINECS: | | Product Categories: | Inhibitors;PI3K;mTOR;Akt | Mol File: | 900185-01-5.mol | |
| PIK-293 Chemical Properties |
density | 1.43 | storage temp. | Store at -20°C | solubility | Soluble in DMSO > 10 mM | form | Powder |
| PIK-293 Usage And Synthesis |
Description | PIK-293 is a cell-permeable, selective inhibitor of the phosphatidylinositol 3-kinase (PI3K) catalytic subunit p110δ (IC50s = 100, 25, 10, and 0.24 μM for p110 subunit isoforms α, β, γ, and δ, respectively). | Uses | PIK-293 is a phosphoinositide 3-kinase delta (PI3Kδ) inhibitor and the parent compound of PIK-294 (P437705). Inhibition of PI3K’s shows to be a promising approach for cancer therapy. |
| PIK-293 Preparation Products And Raw materials |
|